Year: 2024
Type: article
Abstract: translating these findings into clinical applications will involve rigorous preclinical testing, followed by early phase clinical trials to assess the safety and effectiveness of targeting RP11-350G8.5 in patients with MM.Conflict-of-interest disclosure: M.K. declares no competing financial interests.▪
Source: Blood
Author: Lionel Adès
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4403484446